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Low bone mineral density (BMD) is a major risk factor for osteoporotic fracture. Studies of BMD in families and
twins have shown that this trait is under strong genetic control. To identify regions of the genome that contain
quantitative trait loci (QTL) for BMD, we performed independent genomewide screens, using two complementary
study designs. We analyzed unselected nonidentical twin pairs (1,094 pedigrees) and highly selected, extremely
discordant or concordant (EDAC) sib pairs (254 pedigrees). Nonparametric multipoint linkage (NPL) analyses were
undertaken for lumbar spine and total-hip BMD in both cohorts and for whole-body BMD in the unselected twin
pairs. The maximum evidence of linkage in the unselected twins (spine BMD, LOD 2.7) and the EDAC pedigrees
(spine BMD, LOD 2.1) was observed at chromosome 3p21 (76 cM and 69 cM, respectively). These combined
data indicate the presence, in this region, of a gene that regulates BMD. Furthermore, evidence of linkage in the
twin cohort (whole-body BMD; LOD 2.4) at chromosome 1p36 (17 cM) supports previous findings of suggestive
linkage to BMD in the region. Weaker evidence of linkage (LOD 1.0–2.3) in either cohort, but not both, indicates
the locality of additional QTLs. These studies validate the use, in linkage analysis, of large cohorts of unselected
twins phenotyped for multiple traits, and they highlight the importance of conducting genome scans in replicate
populations as a prelude to positional cloning and gene discovery.
Introduction
Osteoporosis is a disease characterized by reduced bone
strength and the development of fractures, particularly
of the spine, hip, and wrist. These fractures usually occur
with minimal trauma and may cause prolonged suffer-
ing, incapacity, and premature mortality. The fractures
may be due to failure to achieve an adequate bone mass
in early adulthood, loss of bone mass with accompa-
nying bone architecture changes with age, or both (Ro-
dan et al. 1996).
Bone mass and susceptibility to osteoporotic fracture
can be assessed by measurement of bone mineral density
(BMD). A low BMD, estimated by dual-energy x-ray
absorptiometry (DEXA), is known to be one of the
strongest risk factors for osteoporotic fracture. Exten-
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sive studies of BMD in twins have shown that at both
axial and appendicular sites, BMD is highly heritable
( ) (Hunter et al. 2001; Recker and2H p 0.50–0.90
Deng 2002). In addition, estimates of heritability in pre-
and postmenopausal women are similar, suggesting that
environmental influences may not diminish the rele-
vance of genetic control of bone mass in older women
(Hunter et al. 2001). Further substantiation that osteo-
porosis may have a genetic basis comes from the ob-
servation that there is familial increase in risk of frac-
ture. Keen et al. (1999) demonstrated that the risk of
wrist fracture may be increased as much as fourfold for
a woman who has a first-degree relative who has also
had this type of fracture. Moreover, it is now recognized
that individual genes that regulate BMD are likely to
exert different effects at different body sites and that
different genes may have general (whole-body), site-spe-
cific, and sex-specific effects (MacGregor et al. 1997).
On the basis of this evidence for the genetic regulation
of BMD, genome screens have been conducted in co-
horts of various ethnic groups. The data from previous
linkage studies in humans have highlighted a number
of regions that may contain QTLs for BMD (Devoto et
al. 1998; Niu et al. 1999; Koller et al. 2000) or femoral
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structure (Koller et al. 2001). In relation to BMD, De-
voto et al. (1998) performed whole-genome scans in
seven large pedigrees with recurrent low bone density
and obtained maximum evidence of linkage, by para-
metric analysis, to 11q (LOD 2.08). They also provided
evidence of linkage, using nonparametric analysis, to
1p36 (LOD 2.29) and 2p24-23 (LOD 2.25). Niu et al.
(1999) performed whole-genome scans in 96 Chinese
families. Utilizing data from forearm densitometry,
they reported evidence of linkage for BMD as a QTL
at 2p24-23 (LOD 2.15) and 13q14-21 (LOD 1.67).
Johnson et al. (1997) reported linkage for high bone
mass to 11q12-13 in a single large pedigree. In another
whole-genome scan of healthy white and African Amer-
ican sibs (Koller et al. 2000), linkage was shown for
lumbar spine BMD in the white subset, at 1q21-23,
6p12-11, 11q12-13, and 22q12-13 (LODs of 3.64,
2.13, 1.65, and 1.82, respectively); for femoral neck
BMD, at 5q33-35 (LOD 2.03); and for trochanter
BMD, at 14q31-32 (LOD 1.99). Recently, Karasik et
al. (2002) reported suggestive linkage from multipoint
analysis of trochanter BMD to 21q, with lower LOD
scores for Ward’s BMD at 8q24 and spine BMD to
14q21.3.
In the present study, female twins, unselected for
BMD, were examined. This is a population in which
the BMD and genotype frequencies for bone-related
traits would be expected to be representative of white
women in the United Kingdom. Large numbers of pairs
(11,000) are necessary to provide adequate statistical
power when using the twin-study design, but there is
the advantage that multiple related phenotypes can be
studied simultaneously. In addition, we studied a second
cohort made up of white women from pedigrees con-
taining an extremely discordant or concordant (EDAC)
sibling pair. The EDAC approach provides increased
statistical power because of the selection process (Carey
and Williamson 1991; Risch and Zhang 1996; Dolan
and Boomsma 1998). Genomewide screens of these two
complementary cohorts were used to locate evidence of
QTLs for BMD in what is, to our knowledge, the largest
linkage study reported to date.
Material and Methods
Subjects and Clinical Assessment
Unselected twin pairs.—Twins were identified from
the St Thomas’ UK adult twin registry and were invited
to participate in the study. Female twin pairs were 18–80
years of age and were measured for an extensive range
of clinical phenotypes related to cardiovascular disease,
obesity, diabetes, and osteoporosis. Here, we report only
the data relevant to the study of BMD. Both twins at-
tended the clinic together for the collection of clinical
data, which included age, height, and weight. Measure-
ment of anterior-posterior projection of lumbar spine
(L1–4), total-hip (femoral neck, trochanter, and inter-
trochanter), and whole-body BMD was made using
DEXA (QDR 2000W, Hologic), as described elsewhere
(Hunter et al. 2001). General medical, gynecological, and
lifestyle questionnaires were completed at interview.
EDAC.—Probands were identified from bone-densi-
tometry databases at participating centers or were re-
cruited from newspaper and press advertisements in the
United Kingdom, Belgium, New Zealand, and Australia.
Probands were required to be white women, to be 25–83
years of age, and to have a lumbar spine, femoral neck,
or total-hip BMD Z score !1.5. The use of BMD Z
scores, which define the number of standard deviations
above or below mean of an age-matched control pop-
ulation, provides a correction of BMD for age in the
linkage analysis. The exclusion criteria applied to these
subjects were myeloma, malignancy with skeletal in-
volvement, prolonged use of steroids (15mg/day for 16
mo), anorexia, premature menopause (at !40 years of
age), unstable thyroid disease, primary hyperparathy-
roidism, antiepileptic therapy, history of osteomalacia,
amenorrhea lasting 16 mo, and rheumatoid arthritis.
Each individual who qualified as a proband and had at
least one sister willing to participate was invited to enroll
in the study. Exclusion criteria were also applied to par-
ticipating sibs. Female sibs then underwent lumbar spine
and total-hip DEXA (Hologic). Clinical data (including
age, height, and weight) were recorded, and subjects
completed medical, gynecological, and lifestyle ques-
tionnaires. Two hundred fifty-four families were iden-
tified that contained an EDAC pair comprising a pro-
band and at least one sister with spine, hip, or femoral
neck BMD Z !1.0 or 11.0. These thresholds for BMD
represent the upper and lower 16% of the age-matched
BMD distribution. This design was selected to provide
the most efficient use of genotyping resources. The
EDAC pairs and any available additional sibs were used
for the genome screen. The final group used in the anal-
ysis comprised 587 individuals.
Ethics approval.—All subjects from both cohorts pro-
vided written informed consent, and the institutional
ethics committees of participating institutions approved
the experimental protocols.
Genotyping
Genotyping was performed on DNA extracted from
venous blood. Microsatellite marker–based genotyping
was undertaken using standard ABI Prism (Applied Bios-
ystems) fluorescence-based genotyping methodologies
(Reed 1994; Pritchard 1995). Genome scans included
the analysis of as many as 737 markers on each of the
twins. Specifically, marker loci were amplified in 10-ml
146 Am. J. Hum. Genet. 72:144–155, 2003
Table 1
Composition of Families Used for Two
Whole-Genome Screens
Variable Twins EDAC
No. of families 1,094 254
Total no. of individuals 2,188 587
No. of possible sib pairs 1,094 444
No. of sibs in family:
2 1,094 198
3 0 39
4 0 13
5 0 3
7 0 1
single-plex PCRs in 384-well microtiter plates. Ampli-
fication products were pooled and precipitated and then
combined with loading buffer, formamide, and an in-
ternal size standard (GeneScan-500, Applied Biosys-
tems); products were then separated by size and were
detected using ABI Prism 377 automated sequencers
(Applied Biosystems).
For the EDAC families, the genome scans were per-
formed using HuSNP GeneChips (Affymetrix), as well
as microsatellite markers. The HuSNP GeneChip is a
valid alternative to a microsatellite genome scan with
10-cM marker spacing (Wilson et al. 2000; Thompson
and Reed 2001). However, a disadvantage is the inflex-
ibility and nonuniformity of the genomic distribution of
the marker loci assayed. For the present study, 33 mi-
crosatellite markers were also assayed, to achieve more-
uniform coverage across the genome. In all, as many as
1,008 biallelic and microsatellite markers were included
in this analysis.
Genotypes from both analyses were processed and
maintained within Phenobase (Sequenom), a proprietary
database of clinical and genetic information. Consisten-
cies between genotypes and family relationships and/or
twin zygosity were routinely investigated, and this in-
cluded analysis of identity-by-state relationships in
families. Discrepant pairs and MZ twins identified by
this analysis were excluded from further analyses.
Random duplicate genotyping was routinely undertaken
throughout the study and indicated a genotyping error
rate of !1% for both microsatellite and biallelic-marker
genotyping.
Statistical Analysis
Nonparametric multipoint linkage (NPL) analysis
(MAPMAKER/SIBS, v. 2.0; Kruglyak and Lander 1995)
was performed separately on the twin and EDAC data
sets. Marker loci map positions were determined from
the Ge´ne´thon linkage maps. The positions of marker loci
that were not included in these maps was interpolated
from alternative physical and genetic maps (Center for
Medical Genetics, Marshfield Research Foundation;
UCSC Genome Bioinformatics) which comprised both
the marker in question and the flanking Ge´ne´thon
marker loci (Dib et al. 1996). Those for which a position
could not be accurately determined were excluded from
the analysis. Lumbar spine, total-hip, and whole-body
BMD (g/cm2) or lumbar spine and total-hip BMD Z
scores were analyzed as quantitative traits in unselected
twin pairs or EDAC pedigrees, respectively. Prior to com-
mencement of linkage analysis, the BMD Z score was
recalculated using published normal-range data for the
lumbar spine site (Hologic 1999) and the NHANES III
reference data for the total hip (Looker et al. 1995), to
ensure consistency across the data set. No age correction
of BMD data was necessary for the twin pairs. Some
BMD results (!3%) obtained by use of Lunar instru-
ments were corrected for the difference between the two
types of densitometers, using the published correction
formula (Steiger 1995; Hanson 1996). Simulated P val-
ues, calculated on a chromosomewide and genomewide
basis, were derived using a permutation approach from
a minimum of 500 random reassignments of the phe-
notype data, whereas genotypes were held constant (pro-
prietary software, Sequenom).
All twin pairs were from independent families, and
no additional sibs were considered in the analysis of the
twin cohort. The majority of EDAC families had only
a single sib pair contributing to the analysis (table 1).
However, in some families, genome scanning was per-
formed for as many as seven female sibs, and weighting
for multiple pairwise comparisons was used in the sta-
tistical analyses to minimize bias. Analysis of clinical
data was performed using Statistica (Statsoft, v. 6.0). The
Mann-Whitney U test was used to perform the statistical
analysis of clinical data because of the difference in data
distribution in the two cohorts. Clinical data were ex-
amined for deviation from normal distribution by use
of the x2 test and are presented as median, interquartile
range, and number of individuals.
Results
The median age of the twin cohort was significantly less
than that of the EDAC cohort ( ) (table 2). TheP ! .001
median height of unselected twins was greater than that
of the EDAC cohort ( ); however, the medianP ! .001
BMIs of the two groups were not different ( ).P 1 .05
The strongest evidence of linkage that was found con-
sistently in both cohorts was to spine BMD on chro-
mosome 3 at 69–76 cM (figs. 1 and 2). Neither of these
peaks achieved genomewide significance; however, both
achieved low P values when assessed in the context of
chromosomewide significance (tables 3 and 4). The ap-
proximate support interval for the chromosome 3 link-
ages (flanked by markers D3S1298 and D3S1285) ex-
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Table 2
Clinical Data for Unselected Twins and Subjects from EDAC
Pedigrees
CHARACTERISTIC
MEDIAN (INTERQUARTILE RANGE),
NO. OF INDIVIDUALS AMONG
Unselected Twins EDAC Pedigrees
Age (years) 48.1 (15.6), 2,188 59.0 (16.1), 587a
Height (m) 1.63 (.09), 2,185 1.59 (.09), 535a
Weight (kg) 64.2 (14.3 ), 2,184 61.0 (14.0), 534a
BMI (kg/m2) 24.2 (5.3), 2,184 24.2 (5.4), 534
BMD (g/cm2):
Spine 1.005 (.186), 2,167 .795 (.210), 584a
Total hip .925 (.172), 2,164 .757 (.186), 562a
Whole body 1.141 (.145), 2,168 N/A
a .P ! .001
tend between 64 cM and 91 cM in the unselected twins
and between 62 cM and 82 cM in the EDAC group.
The mean  SD information content (Kruglyak and
Lander 1995) in this interval is for the0.50 0.04
unselected twins and for the EDAC cohort.0.60 0.07
The data from the unselected twins highlighted 11
additional genomic regions with a LOD 11 for the three
phenotypes analyzed (table 3. These included evidence
of linkage to spine BMD on chromosome 1 at 270 cM,
chromosome 3 at 109 cM, chromosome 16 at 67 cM
and chromosome 19 at 66 cM. There was also weak
evidence of linkage to total-hip BMD in four regions
(chromosome 1 at 13 cM, chromosome 4 at 2 cM,
chromosome 6 at 105 cM, chromosome 22 at 10 cM),
and these were different from those linked to spine
BMD. There was suggestive linkage to whole-body
BMD on chromosome 1 at 17 cM, and there was weaker
evidence of linkage on chromosome 11 at 2 cM and on
chromosome 16 at 13 cM. The only evidence of linkage
to more than one phenotype in the same chromosomal
region was for total-hip BMD and whole-body BMD
on chromosome 1. The approximate support interval
extends 31 cM from the p telomere and is flanked by
D1S199. The mean  SD information content in this
interval is .0.52 0.07
Analysis of the EDAC pedigree data defined eight
more genomic locations for the possible presence of
genes that regulate BMD (table 4). Weak evidence for
linkage to spine BMD was shown on chromosome 2 at
203 cM and 221 cM, on chromosome 4 at 115 cM,
and on chromosome 13 at 110 cM. Total-hip BMD in
this cohort showed weak evidence of linkage to chro-
mosome 3 at 32 cM, on chromosome 4 at 83 cM, chro-
mosome 8 at 62 cM, and on chromosome 9 at 69 cM.
There was no concordance between peaks for spine and
hip BMD in this data set. It may be that the evidence
of linkage of total-hip BMD to chromosome 3 at 32
cM reflects the presence of the same gene(s) defined in
both cohorts by spine BMD linkages, which are ∼40
cM away. However, concordance of peaks is normally
restricted to genetic distances !20 cM.
Empirical P values derived using simulations are given
in tables 3 and 4. These are for guidance only, because
of the small number of permutations applied. Although
seven of the peaks achieved a P value !.05 when con-
sidered in the context of chromosomewide significance,
only the peaks at 76 cM on chromosome 3 and 67 cM
on chromosome 16 had a P value !.01.
In contrast to peaks on chromosome 1 at 17 cM (fig.
3A) and chromosome 3 at 76 cM (fig. 3B), which are
supported by evidence from the analysis of other phe-
notypic data within the same cohort or in the other
cohort; chromosome 11 at 2–15 cM (fig. 3C) and chro-
mosome 16 at 67 cM (fig. 3D) have less evidence of
replication. Several other peaks did have weak support
from other phenotypes, and these included chromosome
2 at 203 cM and 221 cM, chromosome 9 at 69 cM,
chromosome 16 at 13 cM, and chromosome 19 at 66
cM, but these data did not reach the threshold of LOD
p1. Furthermore, given the phenotypic correlation be-
tween BMD measurements at different body sites, some
similarity between the multipoint linkage plots for each
of the phenotypes might be expected (e.g., correlation
coefficients for spine BMD and total-hip BMD and for
whole-body BMD and total-hip BMD in unselected
twins are 0.71 and 0.75, respectively). Of these latter
peaks, only the chromosome 19 peak is replicated for
phenotypes from both cohorts (fig. 3E). In the unse-
lected twins, for spine, hip, and whole-body BMD, very
weak evidence of linkage to chromosome 19 was max-
imal between 65 cM and 70 cM (LOD p 1.15, 0.81,
0.46, respectively). Linkage data from the EDAC ped-
igrees for spine and hip BMD was maximal at 54–
58 cM (LODp 0.6 and 0.72, respectively). Although
in this instance the magnitudes of the linkages are not
great, the apparent consistency in both cohorts is
intriguing.
As might be expected from the highly polymorphic
nature of dinucleotide-repeat polymorphisms, the av-
erage information content was higher in the microsat-
ellite screen than in the predominantly biallelic-
marker–based screen (mean  SD and0.64 0.12
, respectively).0.47 0.14
In the unselected twins, the BMD data for lumbar
spine and total-hip sites were normally distributed
( ). The distribution of whole-body BMD in theP 1 .05
unselected twins was leptokurtic ( ). Spine BMDP ! .01
data for the EDAC cohort were not normally distributed
( ) and showed positive skewness and negativePp .01
kurtosis, as might be expected from the selection cri-
teria. Data on total-hip BMD in the EDAC cohort was
not significantly different ( ) from a normal dis-P 1 .05
tribution. This may be a result of the bias toward se-
lection on the basis of spine-BMD criteria in the cohort.
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Figure 1 Genomewide scans for QTL that regulate BMD in 1,094 twin pairs. A, lumbar spine. B, total hip. C, whole body. Equivalent
LOD scores were calculated from the NPL Z scores output by MAPMAKER/SIBS, using the relationship Z2/4.6052 p 1 LOD.
As would be expected from the age of the individuals
and the selection process, the median spine and total-
hip BMD values were lower in the EDAC families than
in the unselected twins ( for each measure; tableP ! .001
2). The probands for the EDAC pedigrees had very low
BMD at both spine and hip sites (median, interquartile
range [number of individuals] 0.723, 0.144 [253] and
0.704, 0.139 [232]). Siblings that qualified as concor-
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Figure 2 Genomewide scans for QTL that regulate BMD in 254 pedigrees containing an EDAC pair. A, lumbar spine. B, total hip.
dant from these pedigrees also had low BMD for both
spine and hip (0.819, 0.166 [220] and 0.753, 0.166
[220], respectively). Data (median, interquartile range
[number of individuals]) for the discordant siblings were
1.064, 0.172 (69) for spine BMD and 0.944, 0.163 (69)
for hip BMD. There was a predominance of pedigrees
selected on the basis of spine-BMD data in the present
study. Thirty-four percent of the total number of ped-
igrees was selected on the basis of spine BMD in the
proband and the concordant sibling, with a further 16%
selected among discordant siblings. This compares with
only 11% and 2%, respectively, when both siblings were
selected on the basis of hip BMD data.
Discussion
In the present study, maximal evidence of linkage to
spine BMD on chromosome 3 (62–91 cM, 3p21.33-
3p14.1) is observed in two independent study popula-
tions. The conventional paradigm for genomewide link-
age analysis and positional cloning has recently come
under criticism when applied to the study of complex
multifactorial diseases, such as diabetes, asthma, car-
diovascular disease, and osteoporosis (Altmuller et al.
2001). However, much of this criticism relates to the
inability of follow-up studies to replicate findings and,
ultimately, to deliver disease genes. Independent repli-
cation of linkage is a fundamental prerequisite for the
commencement of positional cloning studies, and, de-
spite the failure of either peak on chromosome 3 to reach
the accepted threshold for genomewide significance,
these data must be seen as evidence for the presence of
a gene controlling BMD. Our data demonstrate that for
studies of structural such traits as BMD, replication is
possible when large studies are conducted among sub-
jects with comparable ethnic backgrounds.
Since neither peak on chromosome 3 reached ge-
nomewide significance, the issue of combining the data
for further analysis could be considered. However, the
two genome screens have very different study designs,
and each study is subject to a different ascertainment
bias. Furthermore, the marker sets are distinct, so a
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Table 3
Genomic Location of Maximum NPL for BMD Phenotypes in Unselected Twins
Chromosome
Position
(cM)a Phenotype
No. of
Individuals
Maximum
NPL Z
Maximum
LOD Pemp
b
1 13 Total hip 2,139 2.23 1.08 NS
1 17 Whole body 2,158 3.31 2.38 .030
1 270 Lumbar spine 2,161 2.22 1.07 NS
3 76 Lumbar spine 2,161 3.54 2.72 .008
3 109 Lumbar spine 2,161 2.43 1.29 NS
4 2 Total hip 2,139 2.41 1.26 NS
6 105 Total hip 2,139 2.36 1.21 NS
11 2 Whole body 2,158 3.09 2.08 .014
16 13 Whole body 2,158 2.26 1.11 NS
16 67 Lumbar spine 2,161 3.12 2.11 .008
19 66 Lumbar spine 2,161 2.30 1.15 NS
22 10 Total hip 2,139 2.72 1.60 .038
a Distance from the p telomere.
b Pemp p chromosomewide empirically determined P value. .NSp P 1 .05
Table 4
Genomic Location of Maximum NPL for BMD Phenotypes in Families Containing an
EDAC Pair
Chromosome
Position
(cM) Phenotype
No. of
Individuals
Maximum
NPL Z
Maximum
LOD Pemp
2 203 Lumbar spine 583 2.56 1.42 NS
2 221 Lumbar spine 583 2.45 1.30 NS
3 32 Total hip 543 2.25 1.10 NS
3 69 Lumbar spine 583 3.09 2.07 .014
4 83 Total hip 543 2.47 1.32 NS
4 115 Lumbar spine 583 2.81 1.72 .032
8 62 Total hip 543 2.23 1.08 NS
9 69 Total hip 543 2.40 1.25 NS
13 110 Lumbar spine 583 2.55 1.41 NS
NOTE.—Column headings are as defined in table 3 footnotes.
combined data set would contain a very high rate of
missing data; genotypes for markers typed in each study
would be missing for individuals in the other. This cre-
ates substantial computational complexity. Combining
the data and performing a reanalysis would therefore
yield a result difficult to interpret, so we have not at-
tempted to do this.
The approximate support interval for this chromo-
some 3 peak encompasses a broad and relatively gene-
dense region. There are ∼350–400 genes reported in this
area, and a substantial number of these are expressed
in bone. These include the following: parathyroid re-
ceptor 1 (PTHR1), which has a role in skeletal devel-
opment (Zhang et al. 1998) and calcium homeostasis
(Kovacs et al. 2001); tetranectin (TNA), a gene that
may function in mineralization during embryogenesis
(Wewer et al. 1994); and macrophage stimulating 1
(MST1), a gene that produces a protein that may be
capable of stimulating osteoclastic resorption (Kurihara
et al. 1998). Linkage of hip and spine BMD to this
region of chromosome 3 has been reported elsewhere
(Duncan et al. 1999) by researchers who examined mi-
crosatellite markers surrounding 23 candidate genes, in-
cluding PTHR1. They examined just two microsatellite
markers in this region and found suggestive evidence of
linkage of hip BMD to D3S1289 (69.1 cM; LOD 2.7–
3.5) with weaker linkage for lumbar spine BMD to
D3S3559 (63.3 cM; LOD 1.3–1.6). Thus, studies in
three independent cohorts of similar ethnic background
now provide evidence of linkage for BMD to this region
of the genome. We report linkage to spine BMD in both
cohorts, and we found no convincing evidence of link-
age for the total-hip phenotype to this region. One pos-
sibility for this apparent discrepancy may be a predom-
inance of pedigrees that are informative for spine BMD
in our cohorts. The overall power of both studies is
modest, and larger studies will likely be required to
accurately discern whether there are site-specific or gen-
eral effects on BMD.
In the light of these combined data, polymorphisms
within the regulatory elements of the PTHR1 gene con-
tinue to be strongly implicated for a role in the regu-
Figure 3 Comparison of linkage data for lumbar spine (o), total-hip () and whole-body (#) BMD in 1,094 unselected twin pairs and
for lumbar spine ( ) and total-hip () BMD in 254 pedigrees containing an EDAC pair at 1p36 (D1S468 to D1S199) (A), 3p22-14 (D3S1277∗
to D3S1566) (B), 11pter-14 (D11S4046 to D11S904) (C), 16p12-q23 (D16S3068 to D16S515) (D), and 19q13 (D19S414 to D19S571) (E).
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lation of BMD, and it may be appropriate to begin
positional candidate or positional cloning studies in this
region. However, given the broad support interval and
the large number of genes therein, one should be cau-
tious in speculating about the potential known or novel
genes responsible.
Evidence of linkage was also observed with hip BMD
at 1p36 within a 31-cM support interval, a region also
thought to contain 350–400 genes. This peak in our
data also provides replication of published data (Devoto
et al. 1998). Since the first identification of this region
as the possible location of a QTL regulating BMD,
a fine mapping study of the 1p36 region has been
completed (Devoto et al. 2001). Tumor necrosis fac-
tor receptor superfamily, member 1B (TNFRSF1B)
has emerged as one of the leading candidates. In a recent
preliminary report, Spotila et al. (2001) have shown
significant association of spine BMD to an M196R poly-
morphism in this gene. Albagha et al. (2002) have pro-
vided further support for a role of TNFRSF1B in the
regulation of BMD. They reported an association be-
tween BMD and genetic variation within the 3′ UTR of
the gene, but it must be noted that the effect in that
study was not mediated by the M196R polymorphism.
Another candidate, procollagen-lysine, 2-oxoglutarate
5-dioxygenase (PLOD), which encodes an enzyme that
catalyzes the hydroxylation of lysyl residues in colla-
genlike peptides, failed to show association with BMD
(Spotila et al. 2001). There are a substantial number
of other genes in this region with known expression
in bone. Further work will be required to determine if
TNFRSF1B is responsible for the observed linkage in
both studies.
Among our results, weak evidence of linkage of
whole-body BMD to 11p does not appear to be sup-
ported by data from other phenotypes in our cohort or
the existing literature. The LRP5 locus is on chromo-
some 11 and has been reported to have a role in con-
trolling BMD variability (Little et al. 2002), but it is at
11q13, 140 cM away from this peak. Similarly, weak
evidence of linkage of spine BMD to chromosome 16
also remains unsupported. Among the peaks that
achieved a LOD of 1–2.3, the chromosome 2q peak for
spine BMD in the EDAC pedigrees and the peak for
spine BMD in unselected twins on 19q are probably the
most interesting. Hocking et al. (2001) have reported
suggestive linkage in families with Paget’s disease to
2q36, a region within the approximate support interval
of this linkage peak. This region contains a number of
important candidate genes, including insulinlike growth
factor binding proteins 2 and 5 (IGFBP2 and IGFBP5)
and Indian hedgehog (IHH) genes (National Center for
Biotechnology Information). The chromosome 19 sup-
port interval encompasses both transforming growth
factor–b1 (TGFb1) and apolipoprotein E (ApoE) genes,
among others. Genetic variation in both these genes
has been shown to be associated with BMD (Shiraki et
al. 1997; Grainger et al. 1999; Salamone et al. 2000;
Keen et al. 2001). Whether other genes in this region
also contribute to the variance in BMD remains to be
determined.
Numerous other regions of the genome have been
highlighted from genomewide screens of humans and
provide possible locations for other genes that may par-
ticipate in the regulation of BMD, but they are not
supported by our data. These include 1q21-23q, 11q12-
13, and 14q21.3, among others (Johnson et al. 1997;
Koller et al. 2000; Karasik et al. 2002). Consideration
of this issue could include the possibility of false neg-
atives in our data and of false positives in these other
published reports. Other potential sources of difference
include ethnic background, differences in exposure to
environmental factors that might modulate the effects
of the genes (e.g., calcium intake or sunlight exposure)
and variations in study design (including selection
criteria, menopausal status, sample size, and linkage
marker selection).
We chose three sites for the study of BMD, since they
represent an economical design for consideration of the
two main clinically relevant sites for osteoporotic frac-
ture (spine and hip) plus an overall assessment of gene
effects (whole body). Although other sites (e.g., the fore-
arm) might have been examined, the data were not
available for all sib pairs, and the clinical relevance of
such measurements is less clear. Similarly, we do not
present analysis of the interrelated BMD hip regions
(e.g., femoral neck, trochanter, intertrochanter, Ward’s),
which are compromised by virtue of the high phenotypic
correlation within the anatomical site.
With respect to the distribution of spine and hip BMD
in the EDAC cohort, one might expect the distribution
to be strongly bimodal. This was not the case. Although
families entered the study by virtue of the presence of
an EDAC pair, many pedigrees included additional sibs
who did not conform to the criteria (table 1). These
were included in the analysis, since they present addi-
tional information on identity-by-descent in the family
and contribute to the linkage analysis, albeit with less
power than highly selected individuals. Moreover, even
members of the EDAC group show within-individual
variation in BMD at various body sites. An individual
who had a measurement of BMD Z !1.5 at the spine
might still have a total-hip BMD of ; thus, theZp 0.2
entire distribution of BMD values is represented in the
cohort. Since we sought to localize genes with major
effect on BMD, whether site specific or not, we have
not restricted the recruitment criteria to a single clinical
site (e.g., lumbar spine). Instead, we have included
spine, hip, and whole-body phenotypes in an attempt
to localize any gene providing substantial regulation of
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BMD. We chose to accept a stringent criterion for the
proband (lowest 6.7% of the age-matched distribution)
but a less stringent criterion for the other sibling (highest
or lowest 15.9% of the age-matched distribution). Our
goal was to enhance the power of the study by selecting
subjects with evidence of a familial trend for low BMD
while maintaining a balance with the practicalities of
recruiting sufficient pedigrees to empower the study.
Although this is a large study in comparison with
some of the genome screens published for BMD to date,
the power of the study remains relatively modest, and
the ability to detect genes of small effect is poor. For
example, Fulker et al (1994) have shown that a sample
size of 200 sib pairs would provide adequate power
(80%–90%, at a significance level of .01) to detect QTL
only if they account for 25% of trait heritability. By
comparison, Risch and Zhang (1996) give sample-size
requirements to detect a QTL with the use of extremely
discordant pairs. They estimate that the number of pairs
required to detect linkage (e.g., LOD 3.0) for a trait of
heritability 0.3, for an additive model, is ∼150 pairs.
Although our EDAC cohort is approximately double
this size, its statistical power appears to be adequate
only for the detection of those genes that explain a rel-
atively large amount of the variance in the trait. The
analysis of the unselected twin cohort includes many
more individuals than that of the EDAC cohort. How-
ever, because the twins are unselected, the power of that
cohort to detect genes of minor effect is also small.
Dolan et al. (1999) have estimated that, for a trait with
heritability similar to that of BMD, 5,000 unselected
twins are likely to be comparable to a sample of 250
EDAC pairs drawn from 15% of the distribution. Thus,
despite the size of the cohort, the power of the unse-
lected-twin study is probably similar to that of the
EDAC cohort.
Two distinct, but complementary, approaches were
used in the present study to define the location of QTLs
for BMD in white women: one unselected and one
highly selected. Large numbers of unselected DZ twins
are available in the general population, and many coun-
tries maintain twin registers, making these an ideal re-
source for large-scale linkage studies. Such schemes do
not generally exist for sibling pairs, who are also more
difficult to recruit than twins. Unselected twins might
be expected to be a good model for linkage studies of
complex diseases in the population at large, because
twins have been shown to be comparable to general
population singletons for a range of chronic age-related
phenotypes, including BMD and other bone parameters
(Andrew et al. 2001). Furthermore, extensively phen-
otyped twins represent an economical study design for
the simultaneous completion of multipoint linkage stud-
ies of several complex diseases for the cost of a single
genome screen. In contrast, the use of highly specific
selection criteria, as required for an affected sibling pair
or EDAC design, effectively prohibits the cohort from
being used in the study of other diseases. For example,
because BMD was the selection criterion for this study,
there were insufficient data to study the important clin-
ical endpoint of vertebral fracture. Other data, such as
bone- and calcium-metabolism–related biochemistry,
were also lacking in the EDAC cohort, but analysis of
these phenotypes will be possible for the unselected
twins in the future. Selected study designs are generally
regarded as a more cost-effective design than similarly
sized unselected cohorts, for the detection of linkage for
a single phenotype. Certainly, the perception of econ-
omy in the use of the EDAC design appears to be sup-
ported by our data. We analyzed many more unselected
twins than EDAC family members.
For many complex diseases, age is crucially important
in disease expression. Because of the precisely shared
age—and, usually, a shared upbringing—for twins, a
number of common important environmental influ-
ences, such as sunlight exposure, childhood exercise,
and calcium intake, are also controlled (MacGregor et
al. 2000). Little reliable information on shared upbring-
ing is available to compare between siblings in our
EDAC cohort, and the higher median age of this group
suggests a substantially greater period of influence of
environmental factors that might affect BMD. Such fac-
tors may not act equally on both sibs, and the increased
environmental variance may be one cause of the lower
number and magnitude of linkage peaks observed for
this cohort, compared with the unselected twins. How-
ever, it must also be noted that some of the linkage peaks
observed in one cohort and not the other could be due
to differences in marker number or distribution, which
vary across the genome in the marker sets we used.
Therefore, evidence of linkage in only one cohort is not
a sufficient reason to support rejection of a region from
consideration for further study.
In conclusion, the present article details what is, to
our knowledge, the largest genome screen for the study
of linkage for BMD reported to date. The number and
magnitude of the linkage peaks—and the concordance
of peaks from the analysis of unselected twins with those
from our EDAC genome screen and the literature—
provide evidence for the value of our approach. This is
particularly well illustrated by replication of the linkage
of spine BMD to 3p21 and total-hip and whole-body
BMD to 1p36. We have identified two genomic regions
for which there is now strong evidence of the presence
of genes that regulate BMD. Replication of these find-
ings is provided within our own data, as well as in the
literature. Although the approximate support intervals
for these regions remain relatively broad, these data
provide an important advance toward identifying ap-
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propriate genomic regions for the commencement of
positional-cloning or positional-candidate studies.
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